OUR VISION
Supply chain oversight partner.
To be the supply chain oversight partner of choice for International Pharma /Biopharma companies for product release into Europe.
MIAS INSIGHT
Latest Market & MIAS Updates.
GMP/GDP Audits & the Importance of CAPA
The conduct of audits is a key part of our Pharmaceutical Quality Systems to give us information on the activities and
Brexit and the Evolving Impact on the Pharmaceutical World
Brexit took place at 11pm on 31 Jan 2020 as the UK departed from the European Union. A transition period of
New QTA requirements with Importation Site
The manufacture of pharmaceutical products for the EU, including active substances and medicinal products, frequently occurs outside of the Union. As